(To see other currencies, click on price)
MORE ABOUT THIS BOOK
Main description:
The Ernst Schering Research Foundation sponsored its 15th workshop in Berlin on October 19-21, 1994. Leading scientists from Europe and North America were invited to discuss computer-aided drug design in industrial research. Computer-aided drug design is a very exciting field and an intellec tual challenge, like playing chess. But these reasons are no longer suf ficient to justify using this method in industry, if they ever were. Fig. 1. The participants of the workshop VI Preface Therefore, when we, together with Prof. Hoyer, started to think about this workshop, our intentions quickly became clear. We were not so much interested in the very latest developments of methods or in computer-aided drug design itself - enough conferences have dealt with these topics. However, we were very interested in the usefulness and limitations of computer-aided drug design in the indu strial research process. A lot has changed in the pharmaceutical industry recently. These changes are gaining momentum, so it is the right time to think about the role of computer-aided drug design in this changing environment.
Contents:
1 Some Aspects of Computational Chemistry.- 2 Computer-Aided Drug Design in Industrial Research - A Management Perspective.- 3 Reflections on Collaborations of a Computational Chemist with Medicinal Chemists and Other Scientists.- 4 Structure-Based Ligand Design.- 5 Chances and Risks of Modeling in Industry.- 6 The Advantages of Using Rational Drug Design in Modern Drug Discovery: How to Integrate Computer-Aided Drug Design and Modern Biotechnology.- 7 Screening Three-Dimensional Databases for Lead Finding.- 8 Optimization of Peptide Leads and Molecular Modeling.- 9 Quantitative Structure-Activity Relationships and Crystallography in Industrial Drug Design.- 10 The Role of Structure-Based Ligand Design in Industrial Pharmaceutical Research.- 11 Drug Design Methods in Real-Life Situations: Recent Examples and Future Opportunities.- 12 Theoretical Chemistry as Part of the Interdisciplinary Approach to Rational Drug Design.- 13 Computer-Aided Drug Design in Industry: A Summary of Perspectives.- Previous Volumes Published in this Series.
PRODUCT DETAILS
Publisher: Springer (Springer-Verlag Berlin and Heidelberg GmbH & Co. K)
Publication date: November, 2012
Pages: 254
Weight: 359g
Availability: Available
Subcategories: Biochemistry, Pharmacology
From the same series
Harald Renz
Alexei Bogdanov
W Wohlleben
P.H. Seeberger
P.A. Schubiger
Bernhard Haendler
Eugene Butcher
Kenneth S. Korach
Shelley L. Berger
H. Graf
John Morser
Heinz-Peter Schultheiss
Andreas Radbruch
S. Bernhard
R. Krattenmacher
Lechoslaw Turski
R.B. Lichtner
H. Graf
Ulrich Dirnagl
I. Schlichting
Kristof Chwalisz
A. Rosenthal
Richard Horuk
Khusru Asadullah
Hinrich Gronemeyer
J. Lindenmann
Eberhard Nieschlag
Robert E. Sobol
U.-F. Habenicht
Markus Schwaiger
R.G.G. Russell
F. Diederich
H. Seidel
Herbert Waldmann
H. Kettenmann
J.A. Dormandy
O. Pelkonen
V. Hansson
Martin Tenniswood
K. Beyreuther
W. Sterry
Peter H. Seeburg
C.N. Serhan
C. Bezold
Jack R. Jr. Lancaster
A. Haverich
Kenneth S. Korach
C. Nüsslein-Volhard
John Eppig
Reinhard Ziegler
Erwin F. Wagner
A. Cockburn
Peter Ramwell
Orla M. Conneely
Guido Kroemer
Burkhart Schraven
Bernhard Haendler
Manfred T. Reetz
Bernhard Haendler
Guido Kroemer
Stefan Jaroch
Orla M. Conneely
Burkhart Schraven
Bernhard Haendler
Andreas Radbruch
P.H. Seeberger
Kenneth S. Korach
B. Weiss
P.A. Schubiger
John Morser
Stefan Jaroch
Shelley L. Berger